Analysis of Radioligand Therapy Components Using Reversed-Phase and HILIC Columns

Applications | 2025 | WatersInstrumentation
HPLC, Consumables, LC columns, LC/MS, LC/MS/MS, LC/QQQ
Industries
Pharma & Biopharma
Manufacturer
Waters
Downloadable PDF for viewing
 

Similar PDF

Predictable Isolation of Radioligand Therapy Precursor PSMA-617 and Closely Eluting Impurities from a Forced Degradation Study Using a MaxPeak™ Premier OBD™ Preparative Column
Development and Optimization of a HILIC- MS Separation of 17 Free Amino Acids using an XBridge Premier BEH Amide Column
Analysis of Underivatized Bisphosphonate Drugs Using HILIC-MS
Improved Separation of RNA Nucleotides,  Nucleosides, and Nucleobases on Atlantis  Premier BEH Z-HILIC Columns